GlaxoSmithKline
GSK
#217
Rank
$57.97 B
Marketcap
$29.43
Share price
0.24%
Change (1 day)
-22.82%
Change (1 year)

Market capitalization of GlaxoSmithKline (GSK)

Market cap: $57.97 Billion

As of October 2022 GlaxoSmithKline has a market cap of $57.97 Billion. This makes GlaxoSmithKline the world's 217th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of GlaxoSmithKline from 2001 to 2022

End of year Market Cap

Year Market cap Change
2022$57.97 B-46.86%
2021$109.10 B18.9%
2020$91.76 B-21.15%
2019$116.38 B23.9%
2018$93.93 B6.6%
2017$88.11 B-6.48%
2016$94.22 B-4.88%
2015$99.05 B-4.91%
2014$104.16 B-19.26%
2013$129.00 B21.97%
2012$105.76 B-8.18%
2011$115.19 B13.05%
2010$101.89 B-7.08%
2009$109.65 B13.45%
2008$96.66 B-30.35%
2007$138.78 B-8.6%
2006$151.83 B3.03%
2005$147.36 B4.74%
2004$140.69 B6.84%
2003$131.68 B16.71%
2002$112.83 B-26.62%
2001$153.76 B

End of Day market cap according to different sources

On Oct 2nd, 2022 the market cap of GlaxoSmithKline was reported to be:

$57.97 Billion
by Yahoo Finance
$57.97 Billion
by CompaniesMarketCap
$59.85 Billion
by Nasdaq
$59.85 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$166.30 B 186.85%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$245.59 B 323.62%๐Ÿ‡บ๐Ÿ‡ธ USA
$94.76 B 63.45%๐Ÿ‡ซ๐Ÿ‡ท France
$218.16 B 276.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$166.73 B 187.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
$8.62 B-85.13%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$1.32 B-97.72%๐Ÿ‡บ๐Ÿ‡ธ USA